N&PD Moderators: Skorpio
You should upgrade or use an alternative browser.Tasimelteon
endotropic
Bluelight Crew
endotropic
Bluelight Crew
That's not what I meant to say, just that we shouldn't expect a qualitatively different experience from other Melatonin 1/2 agonists. Higher affinity is still useful compared to lower affinity because you can take less drug to get the same effect, which in general reduces the risk of off-target side effects.
I think the real advantage of Ramelteon and Tasimelteon compared to melatonin proper is their increased duration. Melatonin with a half life in the ~30min range really has a short "sweet spot" to get to bed before the effects wear off, these new drugs should avoid that problem mostly.